May 14, 2026
Subcutaneous Peptide Delivery: Bioavailability Models
Subcutaneous peptide delivery: bioavailability data, PK models, depot formulations, and SC vs IV vs oral route comparisons in preclinical animal studies.
RESEARCH NOTES
Research.
Read →
May 13, 2026
Oral Peptide Enteric Coating: Release Mechanism Research
Enteric coating oral peptide research: pH-responsive polymers, dissolution thresholds, release mechanisms, and in vitro testing for preclinical studies.
May 13, 2026
Orforglipron: Oral GLP-1 Small Molecule Research (2026)
Orforglipron GLP-1 research: non-peptide small molecule, oral bioavailability, ATTAIN phase 3 data, and mechanistic comparison to semaglutide and tirzepatide.
May 6, 2026
Oral GLP-1 Delivery Innovations: 2026 Research Review
Explore 2026 preclinical evidence on oral GLP-1 delivery innovations—SNAC, ionic liquids, nanoparticles, and enteric coatings—all for research use only.
May 6, 2026
Oral Peptide Half-Life in the GI Tract: Preclinical Data
Preclinical pharmacokinetic data on oral peptide half-life across BPC-157, GLP-1 analogs, TB-500, GHK-Cu, and Epithalon across GI tract compartment models.
May 6, 2026
Oral Peptide Formulation Advances: 2026 Preclinical Data
2026 preclinical evidence on oral peptide formulation advances: enteric coatings, lipid carriers, PLGA microspheres, and absorption enhancers compared.
May 6, 2026
Oral BPC-157 Bioavailability: Preclinical Findings
Explore oral BPC-157 bioavailability data from rodent preclinical models, covering absorption mechanisms, pharmacokinetics tables, and key research limitations.
May 6, 2026
Oral vs Injectable Peptide Research: 2026 Comparison
Oral vs injectable peptide research: preclinical comparison of bioavailability, half-life, tissue distribution, research protocol design and 2026 data.
May 6, 2026
Oral GLP-1 Analogs: Delivery Challenges for Research
Oral GLP-1 analogs delivery challenges: preclinical pharmacokinetics, degradation barriers, formulation strategies and 2026 research compound comparison data.
May 6, 2026
Oral BPC-157 vs Injectable: Preclinical Stability Data
Oral BPC-157 vs injectable: direct preclinical stability comparison covering bioavailability, half-life, GI tract survival, and what animal models demonstrate.